Spruce Biosciences, Inc. (SPRB) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts SPRB Hot Sheet
Join SI Premium – FREE
Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q2 EPS of ($0.22), $0.10 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $1.5 million.
For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Western Midstream prices $700M in senior notes due 2036
- FTI Consulting names Jerome Nyssen senior managing director in Australia
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
